GeneDx Holdings Corp. Class A Common Stock (WGS) is a publicly traded Healthcare sector company. As of August 19, 2026, WGS trades at $75.90 with a market cap of $2.31B and a P/E ratio of -20.81. WGS moved -1.34% today. Year to date, WGS is -41.30%; over the trailing twelve months it is -39.36%. Its 52-week range spans $32.21 to $170.87. Analyst consensus is strong buy with an average price target of $85.00. Rallies surfaces WGS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for WGS, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $75.90 |
| Market Cap | $2.31B |
| P/E Ratio | -20.81 |
| EPS | $-3.63 |
| Dividend Yield | 0.00% |
| 52-Week High | $170.87 |
| 52-Week Low | $32.21 |
| Volume | 327.13K |
| Avg Volume | 0 |
| Revenue (TTM) | $454.43M |
| Net Income | $-106.36M |
| Gross Margin | 69.37% |
8 analysts cover WGS: 0 strong buy, 8 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $85.00.